A needle-free drug delivery company utilizing the FcRn receptor to transport macromolecules across epithelial barriers in the central airway and into circulation. FcRn is a natural transport pathway for immunoglobulin G that is found in human mucosal epithelial cells. In February 2007, Syntonix was acquired by Biogen Idec (NASDAQ:BIIB).
Syntonix Pharma
